By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences today said that it has raised $1.2 million from the exercise of preferred stock purchase warrants.

The firm said that 98,372 15-month preferred stock purchase warrants were exercised, representing 100 percent of all outstanding and unexercised 15-month warrants that could be exercised after the March 30, 2010 warrant call.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.